Bayesian Capital Management, LP Medtronic PLC Transaction History

Bayesian Capital Management, LP

$838 Million
Q3 2024

A detailed history of Bayesian Capital Management, LP transactions in Medtronic PLC stock. As of the latest transaction made, Bayesian Capital Management, LP holds 93,200 shares of MDT stock, worth $7.44 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

93,200

Previous 41,900 122.43%

Holding current value

$7.44 Million

Previous $3.3 Million 154.47%

% of portfolio

1.0%

Previous 0.39%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.84 - $91.03 $3.94 Million - $4.67 Million	51,300 Added 122.43%	93,200 $8.39 Million
Q2 2024 Aug 14, 2024	BUY	$78.71 - $87.02 $3.3 Million - $3.65 Million	41,900 New	41,900 $3.3 Million
Q4 2023 Feb 14, 2024	SELL	$69.43 - $83.43 $4.8 Million - $5.77 Million	-69,100 Reduced 67.49%	33,278 $2.74 Million
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $2.31 Million - $2.67 Million	29,500 Added 40.48%	102,378 $8.02 Million
Q2 2023 Aug 14, 2023	BUY	$79.47 - $91.38 $5.79 Million - $6.66 Million	72,878 New	72,878 $6.42 Million
Q4 2022 Feb 14, 2023	SELL	$76.18 - $87.74 $5.07 Million - $5.84 Million	-66,600 Reduced 62.49%	39,978 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $6.51 Million - $7.68 Million	80,600 Added 310.26%	106,578 $8.61 Million
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $847,780 - $1.1 Million	9,700 Added 59.59%	25,978 $2.33 Million
Q1 2022 May 16, 2022	BUY	$100.58 - $112.38 $1.64 Million - $1.83 Million	16,278 New	16,278 $1.81 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $2.36 Million - $2.6 Million	-19,200 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $1.05 Million - $1.17 Million	-8,900 Reduced 31.67%	19,200 $2.38 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $2.92 Million - $3.15 Million	26,300 Added 1461.11%	28,100 $3.32 Million
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $181,026 - $210,852	1,800 New	1,800 $211,000
Q4 2019 Feb 14, 2020	SELL	$104.49 - $114.54 $5.11 Million - $5.6 Million	-48,900 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$98.02 - $111.18 $862,576 - $978,384	8,800 Added 21.95%	48,900 $5.31 Million
Q2 2019 Aug 13, 2019	BUY	$84.15 - $99.38 $260,865 - $308,078	3,100 Added 8.38%	40,100 $3.91 Million
Q1 2019 May 14, 2019	SELL	$82.45 - $93.79 $2.65 Million - $3.01 Million	-32,145 Reduced 46.49%	37,000 $3.37 Million
Q4 2018 Feb 13, 2019	SELL	$85.8 - $99.49 $368,940 - $427,807	-4,300 Reduced 5.85%	69,145 $6.29 Million
Q3 2018 Nov 14, 2018	BUY	$85.91 - $99.17 $6.31 Million - $7.28 Million	73,445 New	73,445 $7.23 Million
Q1 2018 May 15, 2018	SELL	$76.55 - $87.26 $4.76 Million - $5.43 Million	-62,200 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$76.93 - $83.5 $4.79 Million - $5.19 Million	62,200	62,200 $5.02 Million

Others Institutions Holding MDT

# of Institutions

2,286

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $106B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account

Bayesian Capital Management, LP Medtronic PLC Transaction History